NYU Langone Seaport — New York, New York

NYU Langone Seaport is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Seaport has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Aerovate Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Seaport?

NYU Langone Seaport has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Seaport conducted?

NYU Langone Seaport has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is NYU Langone Seaport accredited by Crixeo Health?

NYU Langone Seaport has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Seaport?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.